Neuroscience research articles are provided.
What is neuroscience? Neuroscience is the scientific study of nervous systems. Neuroscience can involve research from many branches of science including those involving neurology, brain science, neurobiology, psychology, computer science, artificial intelligence, statistics, prosthetics, neuroimaging, engineering, medicine, physics, mathematics, pharmacology, electrophysiology, biology, robotics and technology.
– These articles focus mainly on neurology research. – What is neurology? – Definition of neurology: a science involved in the study of the nervous systems, especially of the diseases and disorders affecting them. – Neurology research can include information involving brain research, neurological disorders, medicine, brain cancer, peripheral nervous systems, central nervous systems, nerve damage, brain tumors, seizures, neurosurgery, electrophysiology, BMI, brain injuries, paralysis and spinal cord treatments.
What is Psychology? Definition of Psychology: Psychology is the study of behavior in an individual, or group. Psychology news articles are listed below.
Artificial Intelligence articles involve programming, neural engineering, artificial neural networks, artificial life, a-life, floyds, boids, emergence, machine learning, neuralbots, neuralrobotics, computational neuroscience and more involving A.I. research.
Robotics articles will cover robotics research press releases. Robotics news from universities, labs, researchers, engineers, students, high schools, conventions, competitions and more are posted and welcome.
Genetics articles related to neuroscience research will be listed here.
Neurotechnology research articles deal with robotics, AI, deep learning, machine learning, Brain Computer Interfaces, neuroprosthetics, neural implants and more. Read the latest neurotech news articles below.
Summary: Researchers have created a new computational method that can accurately predict how one subpopulation of cells can be converted to another.
Source: University of Luxembourg.
Thanks to a newly developed computational method, Luxembourg researchers can accurately predict how one subpopulation of cells can be converted into another. “The method has great potential for regenerative medicine when it comes to replacing cell subpopulations that have been lost in the course of disease, for example,” explains Prof. Dr Antonio del Sol, head of the Computational Biology group of the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg. In collaboration with Parkinson disease’s researchers of Karolinska Institutet, Sweden, the scientists tested the practical feasibility of their method: they showed that, based on the computational predictions, stem cells from the brain could indeed be reprogrammed and ultimately converted into the desired subtype of neurons.
The researchers presented their results in the journal Nature Communications.
Identifying cell types
Skin cells and neurons are not the same, that much is clear just from looking at them. But even cells of the same type can have fine differences in genetic activity that sometimes have a powerful influence on their cellular function, giving rise to different cell subpopulations or subtypes. For example, dopaminergic neurons are nerve cells in the brain that produce the neurotransmitter dopamine. In the course of Parkinson’s disease, these cells in the substantia nigra of the midbrain die off – but not all of them. Only one specific subtype of these cells dies off. “The identity of a particular cell subtype is characterised and maintained by a few interacting regulatory genes”, del Sol explains. “Yet the differences between the subtypes are subtle and difficult to detect using the existing analytical methods.”
In order to address this problem, del Sol and his team developed the computational platform “TransSyn”. Its predictions are based on the gene expression programs of individual cells in a population. Following a multistep computational pipeline, TransSyn searches for subtle differences between cell subtypes. The researchers know there are always multiple, synergistically interacting regulatory genes working together to characterise a subtype. Once these synergistic ‘transcriptional cores’ have been identified for each subtype, there are enough data to move onto laboratory applications, such as converting one cell subtype into another. To do that, the scientists treat cell cultures with specific factors to alter their gene expression profiles. These factors activate certain genes while deactivating others.
Cooperation with the Karolinska Institute
Working from the predictions made in Luxembourg, the researchers at the Swedish Karolinska Institute, converted human neuroepithelial stem cells (hNES cells) from the hindbrain into midbrain dopaminergic neuron progenitors capable of developing into dopaminergic neurons. “This could prove to be a strategy for cell therapy in Parkinson’s disease,” del Sol asserts.
Testing the predictions in the lab
The Luxembourg researchers are continuing to test the applicability of their platform at present, for example in collaboration with the Gladstone Institute in the USA. The American researchers, led by Deepak Srivastava, are looking for an efficient way to convert heart cells of the right ventricle into those of the left ventricle and vice versa – because the two subtypes exhibit subtle differences in their gene expression profiles and thus functional activity. “We have the predictions already. Our colleagues in the US will be starting their experiments in the next few weeks,” del Sol said.
[divider]About this neuroscience research article[/divider]
Source: Thomas Klein – University of Luxembourg Publisher: Organized by NeuroscienceNews.com. Image Source: NeuroscienceNews.com image is credited to University of Luxembourg. Original Research: Open access research for “Transcriptional synergy as an emergent property defining cell subpopulation identity enables population shift” by Satoshi Okawa, Carmen Saltó, Srikanth Ravichandran, Shanzheng Yang, Enrique M. Toledo, Ernest Arenas & Antonio del Sol in Nature Communications. Published July 3 2018. doi:10.1038/s41467-018-05016-8 [divider]Cite This NeuroscienceNews.com Article[/divider]
[cbtabs][cbtab title=”MLA”]University of Luxembourg”Predicting Cell Conversion Factors.” NeuroscienceNews. NeuroscienceNews, 27 July 2018. <https://neurosciencenews.com/ai-cell-conversion-9623/>.[/cbtab][cbtab title=”APA”]University of Luxembourg(2018, July 27). Predicting Cell Conversion Factors. NeuroscienceNews. Retrieved July 27, 2018 from https://neurosciencenews.com/ai-cell-conversion-9623/[/cbtab][cbtab title=”Chicago”]University of Luxembourg”Predicting Cell Conversion Factors.” https://neurosciencenews.com/ai-cell-conversion-9623/ (accessed July 27, 2018).[/cbtab][/cbtabs]
Transcriptional synergy as an emergent property defining cell subpopulation identity enables population shift
Single-cell RNA sequencing allows defining molecularly distinct cell subpopulations. However, the identification of specific sets of transcription factors (TFs) that define the identity of these subpopulations remains a challenge. Here we propose that subpopulation identity emerges from the synergistic activity of multiple TFs. Based on this concept, we develop a computational platform (TransSyn) for identifying synergistic transcriptional cores that determine cell subpopulation identities. TransSyn leverages single-cell RNA-seq data, and performs a dynamic search for an optimal synergistic transcriptional core using an information theoretic measure of synergy. A large-scale TransSyn analysis identifies transcriptional cores for 186 subpopulations, and predicts identity conversion TFs between 3786 pairs of cell subpopulations. Finally, TransSyn predictions enable experimental conversion of human hindbrain neuroepithelial cells into medial floor plate midbrain progenitors, capable of rapidly differentiating into dopaminergic neurons. Thus, TransSyn can facilitate designing strategies for conversion of cell subpopulation identities with potential applications in regenerative medicine.
[divider]Feel free to share this Neuroscience News.[/divider]